Trial Profile
A single dose tolerance and local pharmacokinetic study of topical Aminolevulinic acid hydrochloride in patients with cervical intraepithelial neoplasia (CIN)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2018
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- 28 Jun 2018 New trial record